Results 251 to 260 of about 7,679,983 (331)
Production of a nutrient enriched biochar: a techno‐economic feasibility analysis
Biofuels, Bioproducts and Biorefining, EarlyView.Abstract A techno‐economic feasibility analysis was conducted for a biomass pyrolysis plant that utilized Eucalyptus to produce fertilizer‐enriched biochar. Key parameters – biomass throughput, fertilizer loading, and selling price – were optimized for financial viability using net present value (NPV), internal rate of return (IRR), return on ...
Brendon Trollip, Ryan David Merckel
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt +7 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
Private provision of social insurance: drug-specific price elasticities and cost sharing in Medicare Part D. [PDF]
Am Econ J Econ Policy, 2018 Einav L, Finkelstein A, Polyakova M.
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez +2 more
wiley +1 more source
Dataset on analysis of quality of health and social insurance subscription in different socio-economic class of workers in selected areas in southwest Nigeria. [PDF]
Data Brief, 2018 Dokunmu TM +3 more
europepmc +1 more source
Electronic medicine management systems in developing countries: A landscape review
British Journal of Clinical Pharmacology, EarlyView.Medicines are a major global health expense. However, suboptimal use increases costs and causes patient harm. One way to reduce costs and increase safe, efficient medicines use is with electronic medicines management systems (EMMS). They allow easy capture of routine health data which can facilitate research, service planning and reimbursement ...
Andrew Lambarth +8 more
wiley +1 more source
The Establishment File of the German Social Insurance Statistics
, 2004 Michael Fritsch, Udo Brixy
openalex +1 more source